Pharmerica Stock Hits New 52-Week Low (PMC)

NEW YORK ( TheStreet) -- Pharmerica Corporation (NYSE: PMC) hit a new 52-week low Thursday as it is currently trading at $9.88, below its previous 52-week low of $9.98 with 33,328 shares traded as of 10:55 a.m. ET. Average volume has been 308,200 shares over the past 30 days.

Pharmerica has a market cap of $300.6 million and is part of the services sector and retail industry. Shares are down 33.9% year to date as of the close of trading on Wednesday.

Pharmerica Corporation operates as an institutional pharmacy services company in the United States. It offers services to healthcare facilities and provides management pharmacy services to hospitals. The company has a P/E ratio of 11.7, equal to the average retail industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Pharmerica as a hold. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and poor profit margins. You can view the full Pharmerica Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

null

More from Markets

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers